Today at the Entrepreneurship Competition Hangzhou 2021, Worg pharmaceuticals received the sole first prize of "Innovators in China" and "Zhejiang Great Projects." Worg’s innovative technology platform and five allergy immunotherapy products were presented and well-received by a panel of distinguished judges. This "Innovators in China" and "Zhejiang Great Projects" recognition is yet another honor to Worg Pharmaceuticals after the company was rated as "Zhejiang Quasi Unicorn Enterprise" in April this year.

Worg was founded in 2018 with head quarter in Hangzhou. The company is committed to the development and commercialization of innovative drugs, pays attention to the unmet clinical needs of patients, and is committed to becoming a respected global leading pharmaceutical company. For more information, please visit